Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular

Kenichi Sakakura1, Yoshiaki Ito2, Yoshisato Shibata3

  • 1Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama, 330-8503, Japan. ksakakura@jichi.ac.jp.

Insights

This updated expert consensus document provides the latest techniques and evidence for rotational atherectomy (RA). It addresses the hottest topic in percutaneous coronary intervention (PCI): revascularization strategies for severely calcified lesions.

Area of Science:

  • Cardiovascular Intervention
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Percutaneous coronary intervention (PCI) faces challenges with severely calcified lesions.
  • Rotational atherectomy (RA) is a key technique for treating complex coronary artery disease.
  • Previous expert consensus on RA was published in 2020.

Purpose of the Study:

  • To update the expert consensus document on rotational atherectomy (RA).
  • To incorporate the latest evidence and advancements in RA techniques.
  • To guide the revascularization strategy for severely calcified coronary lesions.

Main Methods:

  • Literature review of recent studies on rotational atherectomy.
  • Analysis of new evidence published since 2020.
  • Expert consensus development based on current data.

Main Results:

  • Significant advancements in RA techniques and devices have emerged.
  • New evidence supports RA as a crucial tool for complex PCI.
  • Updated guidelines reflect contemporary best practices for RA.

Conclusions:

  • Rotational atherectomy remains a vital modality for treating calcified coronary lesions.
  • This updated consensus provides current guidance for interventional cardiologists.
  • Adoption of latest RA advancements can improve PCI outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
25
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17